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2Summary
Protein HMGB1 has long been known as one of the most abundant non-histone proteins in the
nucleus of mammalian cells, and has regained interest recently for its function as an extracellular
cytokine. As a DNA-binding protein, HMGB1 facilitates DNA-protein interactions by increasing the
flexibility of the double helix, and binds specifically to distorted DNA structures. We have
previously observed that HMGB1 binds with extremely high affinity to a novel DNA structure,
hemicatenated DNA loops (hcDNA), in which double-stranded DNA fragments containing a tract of
poly(CA)·poly(TG) form a loop maintained at its base by a hemicatenane. In this paper we show that
the single HMGB1 domains A and B, the HMG-box domain of sex determination factor SRY, as
well as the prokaryotic HMGB1-like protein HU, specifically interact with hcDNA (Kd ~ 0.5 nM).
However, the affinity of full-length HMGB1 for hcDNA is three orders of magnitude higher (Kd <
0.5 pM) and requires the simultaneous presence of both HMG-box domains A and B plus the acidic
C-terminal tail on the molecule. Interestingly, the high affinity of the full-length protein for hcDNA
does not decrease in the presence of magnesium. Experiments including a comparison of HMGB1
binding to hcDNA and to minicircles containing the CA/TG sequence, binding studies with HMGB1
mutated at intercalating amino-acid residues (involved in recognition of distorted DNA structures),
and exonuclease III footprinting, strongly suggest that the hemicatenane, not the DNA loop, is the
main determinant of the affinity of HMGB1 for hcDNA. Experiments with supercoiled CA/TG-
minicircles did not reveal any involvement of left-handed Z-DNA in HMGB1 binding. Our results
point to a tight structural fit between HMGB1 and DNA hemicatenanes under physiological
conditions, and suggest that one of the nuclear functions of HMGB1 could be linked to the possible
presence of hemicatenanes in the cell.
Keywords: alternative DNA conformations; DNA knot and hemicatenane; DNA topoisomers
fractionation in chloroquine gels; high-mobility group proteins; HMG-box domain
3Introduction
The nuclear high-mobility group protein HMGB1 (formerly known as HMG-1 1) is a highly
abundant protein in the nuclei of mammalian cells, present in about one molecule per 10-20
nucleosomes. HMGB1 contains two copies of a polypeptide domain of about 80 amino-acids, the
HMG-box motif, which is found in a large number of proteins collectively referred to as the HMG-
box family of proteins1-3. Despite the fact that sequence conservation of the HMG-box domain
between members of the family is not strict, the HMG-box domains are generally considered as
sharing a common function linked to the characteristics of their interactions with DNA4,5. This is
supported by several lines of evidence: first, the HMG-box family includes many transcription
factors and factors involved in the control of development or differentiation3,4; second, all HMG-box
domains studied so far have shown an affinity for DNA6-8; and third, numerous studies have shown a
modulation of DNA-protein interactions by HMGB1, as this protein can facilitate the assembly of
complexes involved in recombination and transcription (review by Bustin9, see also Bonaldi et al.10)
as well as nucleosome remodelling11. The intracellular role of HMGB1 in association with chromatin
does not preclude other functions, however, such as an extracellular role in mediation of
inflammation mechanisms, tumor growth and metastasis12,13; recent review14).
 HMGB1, as well as many other proteins containing HMG-box domains, can not only exhibit high
affinity to distorted DNA conformations such as supercoiled DNA, four-way DNA junction, DNA
minicircles, cisplatin-modified DNA and DNA bulges (for reviews see 6,7,8,15), they can also actively
distort DNA by bending or looping16-20 or changing DNA-topology18,21,22. We have recently reported
that protein HMGB1 also binds with unusually high affinity to a novel DNA structure,
hemicatenated DNA loops (hcDNA)23-26, obtained by reassociation of the strands of DNA fragments
containing a tract of the CA-microsatellite poly(CA)·poly(TG). In this structure, double-stranded
DNA forms a loop maintained at its base by a hemicatenane, i.e. a junction between two DNA
duplexes in which one of the strands of one duplex passes between the two strands of the other
duplex, and reciprocally (Figure 1). The novelty of this structure, the strength of its interactions with
HMGB1, as well as recent results showing that tumor suppressor p53 also binds to hcDNA with high
affinity27 have encouraged us to further study the interactions of hcDNA with HMGB1 and with
HMG-box protein domains.
The present work was aimed at understanding the high-affinity binding of HMGB1 to hcDNA by
addressing three questions. First, is it the HMG-box domain itself that is responsible for the high
affinity of interaction with hcDNA as is known to be the case with other DNA structures such as
four-way junctions or small DNA circles? Second, is the high affinity of HMGB1 for hemicatenated
DNA loops due to the presence of a hemicatenane or to distortions of DNA resulting from the
4presence of a small loop in the structure? And third, what are the characteristics of the interactions of
HMG-box domains with hcDNA as compared to their interactions with other distorted DNA
substrates?
5Results
Binding specificity of HMGB1 and its domains for hcDNA
The fundamental role of HMG-box domains in the specific recognition of distorted DNA structures
by proteins of the HMG-box family being well established, we first set out to verify whether this
was also true with hcDNA and if the individual domains showed the same binding characteristics as
the full-length proteins. Binding experiments were thus carried out with the domains represented
schematically in Figure 2(a), which were expressed in Escherichia coli as (His)6-fusion proteins and
purified by chromatography (alternatively the AB-didomain was also prepared by tryptic cleavage of
the mammalian protein; see Materials and Methods for detailed information on domain expression
and purification). Figure 2(b) presents a polyacrylamide-SDS gel of the purified domains, showing
the high level of purity that was obtained after FPLC purification. As could be anticipated, the AB
didomain and both individual A and B domains showed a clear specificity toward hcDNA. On the
polyacrylamide gels shown in Figure 3 they bound all of hcDNA while showing no complex
formation with the linear DNA present in the samples. This was observed in interactions of hcDNA
with limiting amounts of the proteins (Figure 3, left panels), as well as in competition experiments
with unlabelled bacteriophage lambda DNA (Figure 3, right panels). The domain B having only the
C-terminal extension, residues 92-180, gave the same result as the domain B extending on both
sides; in contrast, neither the “short” domain B (lacking both N- and C-terminal extensions) nor the
acidic C-terminal domain gave rise to shifted bands (data not shown). Therefore, as is the case with
the other distorted DNA structures, specific binding to hcDNA is again a property of the HMG-box
domain.
Comparison of binding affinities of HMGB1, domains, and mutants: highest affinity of full-
length HMGB1
While sharing hcDNA binding specificity with its HMG-box domains, the full-length HMGB1
protein displayed several unique binding characteristics. First, binding of the full-length protein
resulted in only two retarded bands having well-defined mobilities (Figure 3(a), bands labeled C1
and C2), intermediate retarded bands being never observed upon decreasing the protein
concentration or increasing the competitor DNA concentration. In contrast, the A and B single
domains formed an almost continuous series of many retarded bands (Figure 3(c) and 3(d), left
panels), the decrease in mobility of hcDNA being very small at low protein concentration while
becoming equivalent to the shift of full-length HMGB1 when the concentration of the single
domains was high, reflecting the gradual fixation of several molecules of the domains. Second, the
difference between the full-length protein and its domains was even more striking when hcDNA
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and C2 of HMGB1 with hcDNA were almost completely resistant to the presence of competitor
(Figure 3(a), right panel), only a slight decrease in band C2 being seen at the extremely high
competitor DNA concentration of 400 µg/ml corresponding to a non-specific to specific DNA
weight ratio of 105. In contrast, complexes formed with the B domain were strongly decreased by a
competitor DNA concentration of 40 µg/ml (non-specific to specific DNA ratio = 104) (Figure 3(d)
right) while complexes with the A domain had almost disappeared at the same concentration (Figure
3(c) right).
These observations reflect a strong difference in affinity for hcDNA between HMGB1 and its
domains. Assuming a simple binding model, gel retardation experiments allow for a quick estimate
of binding constants using the formula Kd = [P] - [D]/2, which relates the dissociation constant Kd to
the total protein and DNA concentrations at 50% binding, respectively [P] and [D], this formula
becoming Kd ≈ [P] when [D] << [P], i.e. when the DNA fragment concentration is significantly
lower than Kd. The dissociation constant of full-length HMGB1 could not be directly measured here
since the protein concentration at 50% binding in Figure 3(a) was similar to the DNA fragment
concentration (2 pM), indicating a Kd << 2 pM. (Indeed, previous gel retardation experiments using
DNA concentrations as low as was possible with the detection techniques used24 have shown a Kd
lower than 0.16 pM for HMGB1 binding to hcDNA, i.e. an affinity constant at least equal to the
unusually high value of 5.1012; in accordance the hcDNA-HMGB1 complex was found to be
extremely stable, with a half-life of 70 min). In contrast, with A and B domains the protein
concentration at 50% binding was more than 10 fold higher than the DNA concentration (Figs. 3C,
3D), yielding Kd estimates of ~0.5 nM for both single domains. This similarity in binding affinities
of A and B domains was no longer true with the domain mutants obtained by alanine mutagenesis of
the DNA-intercalating residues, i.e. the residues that intercalate between base pairs in the complex
and have been shown to be important for interactions of HMG-box domains with curved or distorted
DNA28-31. As shown in Figure 3(c), replacement of phenylalanine at position 38 within domain A
resulted in a tenfold lower affinity for hcDNA, with a Kd  of ~5 nM, and its binding to hcDNA was
completely abolished by a 103-fold excess of λ DNA (note that replacement of Phe38 for Ala had no
significant effect on binding of the HMGB1 domain A to linear DNA29, M.Š., paper in preparation).
In contrast, mutations of intercalating residues Phe103 or Ile122 or even the double mutation
Phe103+Ile122 of the domain B did not show a major decrease in hcDNA-binding affinities as
compared to the wild-type domain (Figure 3(d)).
The results with the AB didomain were somewhat unexpected, as three bands could be seen on the
gels (Figure 3(b)). The two upper bands looked very similar to bands C1 and C2 of HMGB1, their
7slightly lower mobility being probably due to the charge difference resulting from the removal of the
acidic C-terminal domain. The lower band 3, which has never been observed with full-length
HMGB1, appeared only at low protein concentration or high competitor amounts and was
consistently observed with the recombinant AB didomain as well as with the didomain obtained by
tryptic cleavage of mammalian HMGB1, as on the gel shown here. Whereas the didomain usually
shows a higher affinity than the complete protein for most distorted DNA structures, this was clearly
not the case here. Binding experiments performed at hcDNA concentrations varying between 1 nM
and 1 pM showed an affinity of the AB didomain that was intermediate between those of the single
domains and of the full-length protein, with a Kd of ~50 pM (data not shown). In addition, linear
DNA was a clear competitor of AB didomain binding to hcDNA (Figure 2(b), right panel). We
consider that the formation of band 3 can have two possible explanations. Either it reflects the fact
that the AB didomain interacts with hcDNA more weakly than HMGB1 and is simply the indication
of a partial destabilization of the complex that occurs at low protein concentration or at a high
concentration of competitor DNA; or the complexes of HMGB1 with hcDNA result from an
extremely cooperative binding of two protein molecules which does not occur with the didomain
AB. While such a cooperative effect cannot be completely ruled out, with full-length HMGB1 we
have never been able to detect any band resembling complex 3 of AB didomain, even at extremely
low concentration of HMGB1 or in the presence of extremely high amounts of competitor DNA, and
therefore we would tend to favor the former hypothesis.
To summarize the above results, while both domains A and B exhibit a high affinity for hcDNA,
the affinity of the full-length HMGB1 protein is more than three orders of magnitude higher, the
presence of the acidic tail with both domains A and B being absolutely required for the highest
specificity.
Binding of the HMG-box domain of SRY to hcDNA
To find out whether other proteins containing the HMG-box domain could also interact with
hcDNA, binding experiments were carried out with the HMG-box domain of the human sex
determination factor SRY. As shown in Figure 4(a) (left panel), the HMG-box domain of SRY could
clearly interact with hcDNA, with a band pattern similar to those obtained with the single domains
of HMGB1. As the HMG-box domain of SRY is able to bind to four-way DNA junctions (4WJ)32
and to specific sites on linear DNA33, we compared the affinities of this domain to hcDNA and to
these two substrates. Figure 4(a) (right panel) shows a comparison of the formation of complexes
with the three labeled substrates in the presence of variable amounts of nonspecific competitor DNA
(DNA from bacteriophage lambda), and demonstrates that the affinities of the HMG-box domain of
SRY for the three substrates studied are in the following order: hcDNA > four-way junctions >
8linear fragment. Therefore all HMG-box domains tested showed a clear binding preference and a
high affinity for hcDNA. We have also demonstrated that the ubiquitous prokaryotic protein HU
could specifically bind hcDNA (Kd ~ < 1 nM), Figure 4(b). Although HU is a structurally and
evolutionarily unrelated protein to HMGB1, both proteins share similar binding properties, such as
DNA bending, supercoiling, compaction and binding to bent DNA34. However, despite their similar
binding properties towards most other distorted DNA substrates, neither the single HMG-box
domains, nor HU protein, nor p53 (our previous work27) could bind hcDNA as specifically as the
full-length HMGB1 protein, which prompted us to further study the characteristics of HMGB1-
hcDNA interactions and to try to define more precisely the target of HMGB1 on this structure.
Binding of HMGB1 to hcDNA is not significantly affected by magnesium
It has been demonstrated that the high affinity of HMGB1 box A for the four-way junction, which
was initially observed with the open form of the junction in the presence of EDTA35, was strongly
decreased in the presence of magnesium ions when the junction adopts the closed form36. Given the
magnesium concentration in the cell, this led to questioning the physiological importance of the
HMG-box domain interactions with four-way junctions. We therefore asked whether the presence of
magnesium could interfere with binding of HMGB1 to hcDNA. Complexes formed in the presence
of magnesium were analyzed by electrophoresis on polyacrylamide gels in the presence of 1, 10, 100
µM or 1 mM Mg++. As shown in Figure 5, addition of Mg++ up to 1 mM (the highest concentration
studied) did not significantly affect the affinity of HMGB1 to hcDNA. A similar result was obtained
with the HMG-box domain of SRY (data not shown). The decrease in the intensity of band C2,
(which presumably corresponds to the binding of a second HMGB1 molecule to hcDNA as
compared to band C1), was the only visible effect of increasing the magnesium concentration. This
decrease in affinity of the second binding site may be due to a change of conformation of hcDNA
upon addition of magnesium, as suggested by the marked change of mobility of free hcDNA relative
to the linear fragment that is observed here at higher magnesium concentrations.
Is it the DNA hemicatenane or the DNA loop that determines the high affinity of HMGB1 for
hcDNA?
Given the presence of a small DNA loop in the hcDNA structure, and given the known affinity of
HMGB1 for DNA minicircles, we studied whether binding of HMGB1 to hcDNA was due to the
presence of a DNA loop, or to the hemicatenane, or to the combined presence of both features.
To try to address this question, we first assumed that the DNA structure was similar in minicircles
and in the loop of hcDNA. DNA minicircles with sizes varying between 66 and 87 bp were prepared
either from DNA fragments with non-repetitive sequences or from fragments containing a 62 bp
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demonstrates a clear binding preference of HMGB1 for hcDNA as compared to 66 bp minicircles of
mixed sequence (Figure 6(a)) and 69 bp CA/TG-containing minicircles (Figure 6(b)). The Kd
observed for HMGB1 binding to minicircles is ~50 pM, corresponding to an affinity constant of
2x1010 in good agreement with the published values of 109-1010 (refs.37,38). Other minicircles of 83
and 87 bp containing mixed sequences and 86 bp containing a CA/TG tract gave very similar results
(data not shown) and did not reveal any sequence preference of HMGB1 for minicircles in the 66-87
bp size range. The binding constant of HMGB1 for minicircles must be compared to the value of
5x1012 found previously for binding to hcDNA in experiments using a DNA concentration lower
than here, 0.16 pM 24. This ratio of more than two orders of magnitude between binding constants is
a first indication of the importance of the DNA hemicatenane in the high affinity of HMGB1 for
hcDNA.
A further indication was obtained by studying a mutant of HMGB1 in which all three intercalating
residues were mutated to alanine, F38, F103, I122 (see Figure 2 above). Figure 6(c) shows that the
mutated protein retained almost completely the affinity of the wild-type protein for hcDNA, only the
formation of band C2 being strongly impaired, which presumably corresponds to the binding of a
second protein molecule to the complex. In strong contrast, the affinity of the mutated protein to 66
bp minicircles was markedly diminished, only the first complex was formed, with an affinity
constant decreasing by two orders of magnitude. The fact that the mutant protein binds strongly to
hcDNA while binding only weakly to minicircles indicates that the DNA loop is not the main
determinant of HMGB1 specificity for hcDNA. Instead it suggests strongly that the high affinity of
HMGB1 is due to the presence of a hemicatenane in the structure.
HMGB1 protection of DNA hemicatenane from nuclease digestion
To further study whether HMGB1 binds to the hemicatenane or to the loop, we also performed
footprinting experiments by digesting hcDNA with nucleases in the presence of HMGB1. The
results obtained with exonuclease III digestion were particularly clear and striking and are shown in
Figure 7. First, the presence of a DNA knot was not a significant obstacle to the progression of the
enzyme, as exonuclease III digestion in the absence of HMGB1 was only very weakly influenced by
the hemicatenane (under the digestion conditions used no pause of the enzyme was observed on
linear DNA, data not shown). In contrast, in the presence of HMGB1 strong pauses of the
exonuclease were observed on both sides of the molecule immediately before the border between the
terminal non-repetitive sequences and the poly(CA)·poly(TG) tract, i.e. at the location of the
hemicatenane. This result strongly suggests that HMGB1 binds at this position and prevents the
progression of exo III, either directly by steric hindrance, or indirectly by stabilizing the knot. In
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either case, the results do not suggest that HMGB1 binds to the DNA loop but are rather in good
agreement with a specific binding of HMGB1 to the hemicatenane.
Modification of DNA minicircles conformation upon HMGB1 binding
The high affinity of HMGB1 to minicircles was originally considered to be due to the strong
curvature of DNA in such circles16,17. However the DNA structure in minicircles much shorter than
the DNA persistence length is not precisely known, and chemical footprinting experiments38 have
shown that sites with a strongly modified structure are present in 75 bp minicircles and might
represent the actual determinants of HMGB1 affinity. To try to better understand the affinity of
HMGB1 for circular DNA, we studied its interactions with minicircles obtained with DNA
fragments longer than the persistence length of DNA. Following circularization of a 258 bp fragment
from plasmid pBR322, relaxed and negatively supercoiled topoisomers were individually purified by
separation on a polyacrylamide gel in the presence of chloroquine (Figure 8(a), see Materials and
Methods for a description of the protocol for chloroquine removal from DNA). The interactions of
HMGB1 with the purified topoisomers (Figure 8(b)) showed two unexpected characteristics. First,
HMGB1 binding resulted in the unusual acceleration of the bands, not in a retardation as generally
observed for protein binding in band shift assays. The presence of HMGB1 in the accelerated bands
was confirmed by supershifting with anti-HMGB1 antibodies (data not shown), and by the fact that
addition of 0.1% SDS to the samples immediately before loading suppressed the accelerated bands
(not shown). The second characteristic of these interactions was that all topoisomers did not interact
similarly with HMGB1, the relaxed ones forming no complex, the most supercoiled ones binding
HMGB1 only weakly, while the highest affinity was observed with topoisomers with linking number
differences of –2 and –3 relative to the relaxed minicircles. This unexpected acceleration of the
bands, which can only be explained by a change of conformation of the minicircles being both
induced by and required for HMGB1 binding, will be further discussed below (see Discussion).
Absence of binding of HMGB1 to Z-DNA
As hcDNA is prepared from DNA fragments containing a CA/TG microsatellite, we performed a
similar experiment with a 258 bp DNA fragment containing a 62 bp tract of poly(CA)·poly(TG).
Since this sequence is known to be able to adopt the Z-form DNA conformation when subject to
topological constraints39,40, this also allowed us to test the possibility that Z-DNA was involved in the
recognition of hcDNA by HMGB1, as previous reports had suggested that HMGB1 could bind
preferentially to brominated poly(CG)·poly(CG) in the Z-DNA conformation41,42. The results (Figure
8(c)) with 258 bp minicircles containing CA/TG are even more striking than above: topoisomer -1
was not bound, while all of topoisomer -2 was strongly accelerated, the other topoisomers being all
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accelerated upon binding but only weakly bound. As expected, antibodies against Z-DNA (a kind
gift of Alexander Rich) bound all the most supercoiled topoisomers (topoisomers -3 to –6), showing
the induction of Z-form by supercoiling, but no preferential interaction of HMGB1 with the
topoisomers containing Z-DNA could be detected. In addition, using the same assay (data not
shown) we did not detect any binding of anti-Z-DNA antibodies to hcDNA.
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Discussion
While HMGB1 has long been known to bind specifically to many distorted DNA structures, the
present work shows several unique characteristics of its interactions with hemicatenated DNA loops.
First, the affinity of the full-length protein is approximately three orders of magnitude higher than
the affinity of its single HMG-box domains or of the HMG-box domain of the sex-determination
factor SRY, whereas with most other DNA structures the difference in affinity is much lower.
Second, unlike what is usually observed, the AB didomain has a lower affinity for hcDNA than the
full-length protein. Third, mutations of the intercalating residues, i.e. of the residues that have been
shown to be important for specific binding of distorted DNA structures, have little effect on binding
to hcDNA. Fourth, the presence of magnesium ions in the buffer has no significant effect on the
interactions, unlike what is observed with four-way junctions. Fifth and most important, HMGB1
affinity for hcDNA is much higher than for the other substrates, the binding constant of 5x1012 being
of the same order of magnitude as the affinity of highly-specific DNA binding proteins for their
recognition sites, such as lac repressor binding to the lac operator or EcoRI restriction enzyme
binding to its cutting site.
An immediate question raised by these observations is the structural feature of hcDNA recognized
by HMGB1. The extremely high affinity of HMGB1 could be due to a strong affinity for DNA
hemicatenanes but it could also be due to the distortion of DNA that results from the presence of a
very small DNA loop in the structure, or to some other features resulting from the combined
presence of both elements, all these possibilities being non-exclusive. Given the fact that hcDNA is
derived from fragments containing the poly(CA)·poly(TG) sequence, the possibility was considered
that Z-form DNA was present in the structure and involved in this affinity. This possibility can now
be ruled out both on the basis of our results and of previous reports in the literature. While the
suggestion of a preference of HMGB1 and HMGB2 for Z-DNA had been made previously41,42,
several articles showed that this was rather a preference of the proteins for brominated
poly(CG)·poly(CG) than a general preference for the Z-DNA conformation by itself42-44. The fact
that we were not able to detect a strong interaction of HMGB1 with Z-DNA in supercoiled DNA
circles containing the CA/TG sequence is in good agreement with the latter reports.
HMGB1 and other HMG-box domains have been shown to bind DNA circles of 75-100 bp with
affinity constants in the order of 109-1010 (refs.37,38). Since hcDNA was prepared from DNA
fragments containing a 62 bp tract of CA/TG, the DNA loop that it contains might be one of the
determinants of HMGB1 affinity. On the other hand, the structural feature of DNA minicircles that
is recognized by HMGB1 is not precisely known. It was initially assumed that minicircles had a
regular circular structure and that HMGB1 binding was simply due to DNA bending, but the results
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obtained recently using osmium tetroxyde and diethyl pyrocarbonate38 suggest that HMGB1 binds to
alternative DNA structures that occur in minicircles much shorter than the persistence length of
DNA. Similarly, the pattern that we observe for HMGB1 binding to topoisomers of DNA
minicircles longer than the DNA persistence length does not suggest a mere binding to curved DNA.
The fact that accelerated bands appear upon HMGB1 binding to the moderately supercoiled
topoisomers, but not to the most supercoiled ones, points to a major change of conformation of the
circles, resulting in a more compact form that migrates faster despite the presence of bound
HMGB1. A similar observation has been done previously for binding of the archaebacterial histone-
like protein MC1 to 207 bp minicircles45. It is interesting to note that the preferential binding to -2
and -3 topoisomers would correspond to a DNA helical twist of ~11.5 bp/turn, which is in accord
with the change in helical twist observed for DNA binding by the Drosophila homolog of HMGB1,
HMGD46,47. By analogy with the fast migration of the supercoiled forms of larger circular DNA
molecules such as plasmids, it could also be suggested that HMGB1 binding induces and/or
stabilizes the writhing of the minicircles, possibly by formation of an 8-shaped conformation. In this
hypothesis the binding site of HMGB1 would be at the DNA crossover, i.e. at a structure similar to
four-way junctions and hemicatenanes.
The mutated form of HMGB1 in which all three intercalating residues have been replaced by
alanines retains a strong binding affinity to hcDNA but has only a weak affinity to minicircles. This
is a strong indication that the affinity of the triple mutant for hcDNA (and therefore also the affinity
of wild-type HMGB1) is not due to the presence of the loop but to the hemicatenane. This is
strengthened by the two orders of magnitude difference between binding affinity constants of
HMGB1 to hcDNA and to minicircles irrespective of the presence of absence of the CA/TG
sequence, as well as by the exonuclease III footprinting experiments revealing a protection of the
hemicatenane site by HMGB1. Further proof that the hemicatenane is the determinant of HMGB1
binding to hcDNA will require the preparation of hemicatenanes of two independent DNA
fragments, no longer connected by a loop. We have prepared hcDNA by using a DNA fragment with
a short restriction site inserted within the repetitive sequence, in order to cut hcDNA in the loop and
to obtain true hemicatenanes. We found that the presence of such a site did not interfere with
hcDNA formation. However we have observed, first, that such restriction sites become difficult to
cut when present in the loop, and, second, that once the loop is cut the hemicatenane becomes
extremely unstable even in the presence of HMGB1 (C.G., L.d.K., and F.S., unpublished results) and
readily dissociates into two duplexes. Therefore other ways will have to be designed in order to
prepare hemicatenanes of distinct DNA molecules, perhaps using the procedure suggested recently
by Bucka and Stasiak for making knotted DNA circles48.
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Since the DNA hemicatenane and the four-way junction both consist in the junction of two
double-stranded DNA molecules, they could be expected to share some degree of structural
similarity. In particular, our finding that the DNA-intercalating residue of the HMGB1 domain A
(Phe38), rather than those of the domain B, is involved in high-affinity binding to hcDNA is in
accord with previous reports on the dominant role of domain A in the structure-specific binding of
HMGB1 protein to four-way-junctions, DNA minicircles, or bent (cisplatin-modified)
DNA18,37,49,50,51,52,53,54. Interestingly, the presence of the C-terminal flanking sequence within the
domain B was sufficient for a strong binding of the domain to hcDNA, with no further increase in
binding upon attachment of the extended N-terminus (the 85TKKKFKD91 sequence), unlike what had
been reported for DNA bending or binding of the domain B to bent (cisplatin-modified) DNA20,54.
Similarly to results obtained with SRY by other authors, data shown here were obtained with a
domain that was only defined on the basis of sequence comparisons, the influence of flanking
sequences having not been investigated. With HMGB1 in contrast, the marked influence of amino-
acid residues adjacent to the HMG-box domains has been well documented, for example the
influence of the seven amino-acids on the N-terminal side of domain B on DNA binding and
bending is extremely striking20,54. A similar investigation would thus deserve to be done not only
with SRY but also with other members of the HMG-box protein family. In particular some proteins
of the family, such as UBF, contain several HMG-box domains. If the situation is similar to HMGB1
where the presence of the two domains is required for maximum affinity, then results with a
combination of domains or with the full-length proteins might be significantly different from results
obtained with single domains.
It has been suggested that the affinity of the HMG-box for four-way junctions was the result of a
structural coincidence with yet unknown biological binding sites, and the functional significance of
these interactions was questioned based on the strong decrease in binding specificity observed in the
presence of magnesium, i.e. under more relevant physiological conditions36. In contrast, HMGB1
and HMG-box domains consistently show a high affinity for binding to hcDNA even in the presence
of high concentrations of Mg++, conditions under which binding to four-way junctions is no longer
detectable. Our results thus point to an exceptional structural fit between HMGB1 and
hemicatenanes, even under physiological conditions, which suggests that the question as to whether
hemicatenanes exist in the cell should be thoroughly investigated, a suggestion strengthened by our
recent observation of a high affinity of tumor suppressor p53 for hcDNA27. While there is no doubt
that the majority of DNA in the genome is in a double-stranded linear structure of the B-DNA type,
the possibility clearly exists for unfrequent alternative DNA structures to be present. On one hand,
hemicatenanes and more generally DNA knots are of great interest as potential intermediates during
15
processes such as recombination or replication that involve more than two strands of DNA. In
particular a role for hemicatenanes in genome function has previously been suggested in relation
with recombination55-60 or replication61-65, and several studies using two-dimensional electrophoresis
on agarose gels under native conditions have shown the existence of junctions between DNA
molecules in vivo that could be either Holliday junctions or hemicatenanes64-69. In addition, a very
attractive possibility would be that hemicatenanes and HMGB1 participate in the general
organization of the genome in chromosomal loops and domains, a suggestion strengthened by the
recent and striking observation of a role of HMGB1 and its yeast homolog NHP6A/B in the
maintenance of genome stability70.
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Materials and Methods
DNA
Hemicatenated DNA loops were prepared with a 120 bp EcoRI-ClaI fragment from plasmid pE10
that contains a 62 bp tract of poly(CA)·poly(TG) inserted in plasmid pUC19 (accession number
X96980, see fragment map Figure 1). The linear DNA fragment containing SRY binding sites was
the 279 bp Sau96I fragment from plasmid pTZ19R, which contains four copies of the consensus
recognition sequence of SRY33. 258 bp DNA minicircles containing no repetitive sequence were
prepared using the 258 bp Sau3AI fragment of plasmid pBR322. 258 bp DNA minicircles containing
the poly(CA)·poly(TG) sequence were obtained using the 258 bp HinP1I-ClaI fragment of plasmid
pE10. DNA fragments were purified by preparative polyacrylamide gel electrophoresis and
electroelution, dephosphorylated with calf intestine phosphatase, 5’-end labeled with polynucleotide
kinase and [γ-32P]-ATP. Topoisomers of 258 bp DNA minicircles were obtained by classical
techniques involving circularization of linear fragments with T4 DNA ligase in the presence of
variable amounts of ethidium bromide, followed by ethidium bromide removal and determination of
DNA linking numbers by electrophoresis on polyacrylamide gels in the presence of 20 µg/ml
chloroquine71,72. 66 bp minicircles of non-repeated sequence were prepared by ligation of 66-bp
duplexes with sticky ends in the presence of protein HMGB1 as detailed20,27. 69 bp minicircles
containing a 62 bp tract of poly(CA)·poly(TG) were prepared similarly by circularization of the 69
bp Sau3AI fragment from plasmid pE10. Four-way DNA junctions were prepared using synthetic
oligonucleotides with sequences identical to the nucleotides used by Bianchi et al.35, one of the four
oligonucleotides being 5’ end-labeled with 32P. After association of the four strands, four-way
junctions were purified on a polyacrylamide gel and electroeluted.
Hemicatenated DNA loops
The procedure for hcDNA preparation was described previously23. In brief, a 120 bp DNA fragment
containing a 62 bp tract of poly(CA)·poly(TG) flanked by non-repetitive sequences is heat-denatured
and the strands are allowed to reassociate at 37° in 50 mM NaCl, 25 mM Tris-HCl pH 7.5, 1 mM
EDTA, in the presence of protein HMGB1 at a concentration of ~5 ng/µl. The complexes of hcDNA
with HMGB1 are then purified by electrophoresis on a polyacrylamide gel in native conditions and
electroeluted. After protein removal by chloroform extraction in the presence of 1% SDS and 1M
NaCl, hcDNA is recovered by ethanol precipitation in the presence of polyacrylamide carrier73,
dissolved in 50 mM NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, and stored at 4°C in low-binding
polypropylene tubes (Axygen)74.
Purification of DNA topoisomers
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Topoisomers, obtained by circularization of labeled DNA fragments in the presence of ethidium
bromide, were individually purified by preparative electrophoresis on 4% polyacrylamide gels (in
6.7 mM Tris, 3.3 mM Na-acetate, 1 mM EDTA, pH 7.8, run at 4°C with buffer recirculation)
containing chloroquine at a concentration of 20 µg/ml both in the gel and in the buffer. After
autoradiography, bands were cut and topoisomers were electroeluted and ethanol precipitated. As
chloroquine is insoluble in ethanol, it coprecipitated with DNA and interfered strongly with further
experiments (DNA-protein interactions, restriction enzyme digestion, etc). Since chloroquine does
not bind DNA very strongly (Kd > 25 µM 75), it could be removed from DNA by a second
preparative electrophoresis, this time on a polyacrylamide gel containing no chloroquine (4%
polyacrylamide gel in Tris-acetate-EDTA buffer, at room temperature, without buffer recirculation).
After electroelution and ethanol precipitation, the absence of chloroquine from the purified
topoisomers was confirmed by their ability to be digested with restriction enzymes (data not shown),
to interact with proteins, and by their normal migration on gels containing no chloroquine (see
Figure 8).
Proteins
Non-recombinant HMGB1 protein was purified from cultured monkey cells (CV1 line) or from
HeLa cells as described76.
HMGB1 domain A (residues 1-87), domain B (residues 85-180), didomain AB (residues 1-180),
full-length protein, and mutants of DNA-intercalating residues of domains A and B were produced
in Escherichia coli as (His)6-fusion proteins, after cloning the corresponding sequences into vector
pET15b (Novagen) which contains a promoter for T7 RNA polymerase and sequences required for
expression of fusion proteins having a polyhistidine tag at their N-terminus. Alanine mutagenesis of
residues Phe38 (domain A) and Phe103, I122 or Phe103+I122 (domain B) was carried out by the
protocol using “chimeras” of the HMG-box domains (M.Š., paper in preparation). After verification
of the constructs by DNA sequencing, the (His)6-fusion protein were produced in E. coli strain
BL21(DE3)pLysS, extracted under non-denaturing conditions and affinity purified on Ni-NTA spin
columns as recommended in the Qiagen instruction manual, and further purified by FPLC
chromatography on a Mono-S column. Alternatively, the AB didomain was prepared by direct
cleavage of HMGB1 from calf thymus with trypsin and purification on a Mono-S column18.
The HMG-box domain of SRY was similarly expressed in E. coli as a (His)6-fusion protein by
cloning the corresponding DNA sequence from plasmid pGEX-2T-SRY containing the human sry
gene (a gift of Marc Fellous and Laura Salas-Cortes) into vector pET15b.
Protein HU was the kind gift of Josette Rouvière-Yaniv.
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Determination of DNA and protein concentrations.
The estimation of binding constants required measurements of DNA and protein concentrations as
accurate as possible. DNA fragments were gel-purified in amounts larger than 10µg and their
concentration was measured spectrophotometrically before kinase labelling. After radioactive
labelling of known amounts of fragments, followed by removal of all unincorporated radioactivity
by chloroform extraction and quantitative ethanol precipitation in the presence of linear
polyacrylamide carrier73, DNA samples were counted in a scintillation counter and specific activities
in cpm/µg calculated. In such a way, DNA amounts could always be known with good precision by
simple counting of the samples. Protein concentrations were determined spectrophotometrically.
Given the uncertainties on molar extinction coefficients in the case of recombinant and mutant
proteins, protein concentrations were confirmed by electrophoresis of variable amounts of the
purified proteins on SDS-polyacrylamide gels, followed by staining with Coomassie blue, gel
scanning with a Molecular Dynamics densitometer, and comparison of the data with a calibration
curve obtained by applying the same procedure on the same gel to serial dilutions of a known
amount of bovine serum albumin or of carbonic anhydrase.
DNA-protein interactions
DNA-protein complexes were formed using a known concentration of labelled DNA as indicated in
the Figure legends (usually corresponding to ~1000-5000 cpm of 32P-labelled DNA per sample), plus
DNA from E. coli or from bacteriophage lambda used as a non-radioactive competitor when
indicated. Incubations were in 25 µl of 50 mM NaCl, 25 mM Tris-HCl pH 7.5, 1 mM DTT, 1 mM
EDTA, plus 0.1% Triton X-100 and bovine serum albumin at 100 µg/ml to prevent any protein
adsorption on tube walls. Samples were incubated at 37° for 30 min and loaded on a pre-
electrophoresed polyacrylamide gel without addition of tracking dye. For experiments in the
presence of magnesium, the EDTA concentration in the samples was kept below 0.1 mM and MgCl2
was added to 1 mM to the incubation buffer. For exonuclease III digestion, complexes formed as
described above were incubated with 10 units of enzyme for 5 min at 25° in the presence of 2 mM
MgCl2.
Gel electrophoresis
DNA-protein complexes were analyzed by electrophoresis on 4% polyacrylamide gels
(acrylamide:bis-acrylamide 29:1) in 6.7 mM Tris, 3.3 mM Na acetate, 1 mM EDTA, pH 7.8, at 4°
with buffer recirculation. Pre-electrophoresis was for 2 hr and migration of the samples was for 4 hr
at 10 V/cm. Gels in the presence of magnesium were identical except that EDTA was not used and
MgCl2 at the indicated concentration was present in the gel and in the buffer.
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Figure 1. Schematic representation of hemicatenated loops and of the model for the mechanism of
their formation. A DNA fragment containing a tract of poly(CA)·poly(TG) (red and blue) flanked by
non-repetitive sequences (green) is heat-denatured and allowed to reanneal. Pairing of the strands in
the repetitive region can occur either in register, reforming the initial double-stranded fragment, or
with a shift, forming an intermediate (a) in which poly(CA) and poly(TG) are paired on part of their
length only. One of the single-stranded ends can then insert in the fork formed by the two single-
strands at the opposite end (b). Pairing of the non-repetitive terminal regions stabilizes the structure
(c) and leads to the formation of a hemicatenated loop (d), a structure in which the double helix is
folded in a loop maintained at its base by a hemicatenane, i.e. the junction of two DNA duplexes
with one strand of one duplex passing between the two strands of the other duplex, and reciprocally.
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Figure 2. Domains of HMGB1 studied in the present work. The domains studied are represented in
(a): domain A was strictly limited to the HMG-box sequences, whereas domain B included 7
residues on the N-terminal side and was extended to position 180 on its C-terminal side (originally
designated domain B7 in 30,54). Positions of the amino-acids that were mutated to alanine in the
mutants used in this work are indicated, F38 (box A), and F103 and I122 (box B). (b): SDS-
polyacrylamide gel of purified proteins, domains and mutants, showing the degree of homogeneity
obtained after FPLC purification. Each lane was loaded with about 5 µg of highly purified protein,
and the gel was stained with coomassie-blue.
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Figure 3. Interactions of HMGB1, domains, and mutants, with hcDNA; effect of protein
concentration (left panels) and of competitor DNA concentration (right panels). The HMGB1
preparation used was the full-length protein purified from mammalian cells (recombinant His-tagged
HMGB1 gave similar results, data not shown). The AB didomain was prepared from mammalian
HMGB1 by tryptic cleavage and FPLC purification (recombinant didomain expressed in E. coli gave
similar results). The single domains were expressed in E. coli (see Materials and Methods). Domain
A marked as Awt contained amino-acids 1-84 and its mutant AF38A had phenylalanine at position 38
replaced with an alanine. Domain B marked as Bwt contained amino-acids 85-180 and its mutants
BF103A and BI122A had respectively phenylalanine at position 103 and isoleucine at position 122
replaced with an alanine, while BF+I was the double mutant. (a) Binding of full-length HMGB1. Left
panel: effect of protein dilution.  Labeled hcDNA concentration was 2 pM (i.e. 4 pg per sample),
protein concentrations obtained by serial dilutions are indicated at the gel bottom. Right panel:
competition with λ DNA. Labeled hcDNA concentration was 50 pM (i.e. 0.1 ng per sample);
HMGB1 concentration: 150 pM in all samples except lane C; competition with λ DNA: 0, 10 ng,
100 ng, 1 µg, 10 µg, the corresponding competitor:hcDNA ratios being indicated at the gel bottom.
(b) Binding of AB didomain. Left panel: effect of protein dilution. Labeled hcDNA concentration
was 200 pM (i.e. 0.4 ng per sample); protein concentrations obtained by serial dilutions are indicated
at the gel bottom. Right panel: competition with λ DNA. Labeled hcDNA concentration was 200 pM
(i.e. 0.4 ng per sample); protein concentration 2 nM; competitor λ DNA: 0, 0.5, 5, 50, 500 ng and 5
µg from left to right, corresponding competitor excess indicated at gel bottom. (c) Binding of
domain A and mutant. Left panel: effect of protein dilution. Labeled hcDNA concentration was 50
pM (i.e. 0.1 ng per sample); protein concentrations obtained by serial dilutions as indicated at gel
bottom. Right panel: competition with λ DNA. Labeled hcDNA concentration was 50 pM (i.e. 0.1
ng per sample); protein concentrations: Awt 2.5 nM, AF38A 10 nM; competitor λ DNA: 0, 10, 100,
1000 ng from left to right, corresponding competitor excess indicated at gel bottom. (d) Binding of
domain B and mutants. Left panel: effect of protein dilution. Labeled hcDNA concentration was 50
pM (i.e. 0.1 ng per sample); protein concentrations obtained by serial dilutions are indicated at the
gel bottom. Right panel: competition with λ DNA. Labeled hcDNA concentration was 50 pM (i.e.
0.1 ng per sample); protein concentration 13 nM (i.e. 3 ng per sample); competitor λ DNA: 0, 1, 10,
100, 1000 ng from left to right, corresponding to the indicated competitor excess. In all panels, lanes
labeled C correspond to controls with no protein added.
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Figure 4. Interactions of the HMG-box domain of SRY and of protein HU with hcDNA. (a) (left
panel), The HMG-box domain of human SRY (amino-acids 58-137) was expressed in E. coli as a
(His)6-tagged protein and affinity-purified. Decreasing amounts of the protein were allowed to
interact with a fixed amount of hcDNA (~50 pM), and the complexes were analyzed by
electrophoresis on a polyacrylamide gel, protein concentration being indicated at the gel bottom.
Lane C: control, no protein added. (a) (right panel), The interactions of SRY HMG-box with four-
way junctions, hcDNA, and a linear fragment containing 4 copies of the SRY consensus recognition
site were analyzed on a polyacrylamide gel. In each case, a fixed amount of labeled DNA (~50 pM)
was incubated with about 3 ng (~10 nM) of protein, with 0, 50 and 500 ng of sonicated E. coli DNA
being present as competitor (competitor excess indicated at the gel bottom). Samples labeled C are
controls with no protein added. (b) (left panel), Binding of HU protein to hcDNA. Increasing
amounts of HU were allowed to interact with a fixed amount of hcDNA (~50 pM) in the absence of
any competitor DNA. (b) (right panel), Fixed amount of HU (1 nM) was mixed with hcDNA (~50
pM), followed by addition of increasing amounts of competitor (unlabeled) DNA. Complexes were
resolved as indicated in (a).
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Figure 5. Interactions of HMGB1 with hcDNA in the presence of magnesium. Labeled hcDNA (50
pM) was incubated with decreasing amounts of protein HMGB1 in the presence of magnesium.
Protein concentrations in pM are indicated at the gel bottom. After incubation, samples were
analyzed on four polyacrylamide gels containing the indicated Mg++ concentrations. Lanes C:
controls, no protein added.
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Figure 6. Comparison of HMGB1 and mutant HMGB1 binding to minicircles and to hcDNA.
Complexes of HMGB1 or of the triple mutant protein were formed with hcDNA, 66 bp minicircles
with a non-repetitive sequence, and 69 bp minicircles containing a 62 bp tract of poly(CA)·poly(TG)
(see Materials and Methods). No competitor DNA was present. Protein concentrations in pM are
indicated at the gel bottom. (a) Binding of HMGB1 to 66 bp non-repetitive minicircles, performed at
two DNA concentrations, 10 pM and 1 pM as indicated at the top of the gels. (b) Binding of
HMGB1 to 69 bp CA-minicircles. (c) Binding of mutant HMGB1 to 66 bp non-repetitive
minicircles. Lanes C: controls, no protein added. Bands labelled C1 and C2 correspond to complexes
with hcDNA, bands labelled circ.c1 and circ.c2 correspond to complexes with minicircles.
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Figure 7. Exonuclease III digestion of hcDNA, and hemicatenane protection by HMGB1. hcDNA,
32P-labelled at a single 5’-end (left half of the gel: EcoRI end; right half: ClaI end), was digested
with exonuclease III either alone or in the presence of increasing amounts of HMGB1 (10 ng, 100 ng
and 1 µg from left to right respectively). The digestion products were analyzed by electrophoresis on
a denaturing 10% polyacrylamide-urea gel and autoradiography. G+A chemical sequencing
reactions were used as markers in both side lanes. The location of the poly(CA)·poly(TG) tract on
the sequence is indicated on the sides of the gel. A strong pause in enzyme digestion in the presence
of HMGB1 is observed at the border between the non-repetitive terminal sequences and the CA/TG
repeat, immediately before the location of the hemicatenane.
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Figure 8. Interactions of HMGB1 with individual topoisomers of a 258 bp DNA fragment.
(a) Topoisomer purification. The 258 bp Sau3AI fragment from pBR322 was purified, 5’-end
labeled, and circularized by ligation at low fragment concentration (<1 nM)) in the presence of
different amounts of ethidium bromide (from 0 to 2.5 µg/mL in samples a-f, sample g containing the
unligated DNA fragment) to obtain a series of circular topoisomers of the fragment. After ethidium
bromide removal, the samples were analyzed by electrophoresis on 4% polyacrylamide gels, either
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in the absence or in the presence of chloroquine (20 µg/mL). Autoradiograms of the gels are shown
(a, two panels on the left), with the positions of the linear fragment (lin.) and of the six topoisomers
that could be obtained, labeled 0 to –5 according to their linking number differences with the
topoisomer 0 obtained in the absence of ethidium bromide, which was taken as reference. Minor
bands on the gels correspond to linear oligomers and their circular forms. Individual topoisomers
were cut from a preparative gel containing chloroquine and purified as described in Materials and
Methods. A chloroquine-containing gel of the purified topoisomers is shown in (a), right panel
(topoisomer –2 missing due to shortage of material).
(b) Interactions of HMGB1 with purified topoisomers of a labelled 258 bp fragment. The linking
number differences of the topoisomers are indicated at the bottom of the gel, the topoisomer relaxed
in the conditions of the experiment being taken as reference. Each sample contained ~50 pg, i.e. ~15
pM, of 32P-labeled topoisomer: For each topoisomer a series of four samples was made: one control
with no protein added, and three samples containing the same amount of HeLa HMGB1 (~600 pg,
i.e. ~1 nM) and three different amounts of unlabeled competitor DNA (lambda phage DNA, 20 ng,
200 ng, 2 µg, from left to right, respectively; omission of competitor DNA resulted in streaking of
the samples due to low affinity of HMGB1 for all minicircles). An autoradiogram of the gel is
shown.
(c) Interactions of HMGB1 with circular topoisomers containing a tract of CA/TG. Topoisomers of a
32P-labeled 258 bp fragment from plasmid pE10 containing a 62 bp tract of poly(CA)·poly(TG) were
purified on a chloroquine-containing polyacrylamide gel. The topoisomers (~50 pg, i.e. ~15 pM as
above), in the presence of 100 ng lambda phage DNA, were incubated with HMGB1 (~600 pg, i.e.
~1 nM), or with antibodies against Z-DNA, and complexes were analyzed on a polyacrylamide gel.
Autoradiograms show the purified topoisomers (left), their interactions with HMGB1 (center), and
the binding of anti-Z-DNA antibodies to the most supercoiled circles (right). The linking number
differences of the supercoiled topoisomers relative to the relaxed circles are indicated at the bottom
of the gels. o.c.: open (nicked) circles.
